Guodong Deng

590 total citations
30 papers, 392 citations indexed

About

Guodong Deng is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Guodong Deng has authored 30 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Guodong Deng's work include Cancer Immunotherapy and Biomarkers (7 papers), Cancer Cells and Metastasis (5 papers) and Immune cells in cancer (5 papers). Guodong Deng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Cancer Cells and Metastasis (5 papers) and Immune cells in cancer (5 papers). Guodong Deng collaborates with scholars based in China, United States and Germany. Guodong Deng's co-authors include Ning Liang, Jiandong Zhang, Jingxin Zhang, Lili Qiao, Hui Luo, Jian Xie, Jiandong Zhang, Qiqi Liu, Jian Xie and Pingping Hu and has published in prestigious journals such as Scientific Reports, British Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Guodong Deng

29 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guodong Deng China 12 175 162 122 79 73 30 392
Carlo Fremd Germany 12 264 1.5× 100 0.6× 131 1.1× 115 1.5× 69 0.9× 25 455
Bogang Wu United States 10 190 1.1× 126 0.8× 98 0.8× 46 0.6× 37 0.5× 22 379
Anxo Martínez-Ordóñez Spain 10 193 1.1× 180 1.1× 111 0.9× 144 1.8× 50 0.7× 15 434
Conall Hayes Ireland 8 247 1.4× 139 0.9× 179 1.5× 95 1.2× 76 1.0× 16 447
Chen Hao Lo United States 10 167 1.0× 148 0.9× 132 1.1× 76 1.0× 77 1.1× 17 366
Michael M. Allevato United States 7 145 0.8× 178 1.1× 79 0.6× 61 0.8× 56 0.8× 15 336
Wen Meng China 10 126 0.7× 264 1.6× 169 1.4× 189 2.4× 103 1.4× 16 528
Yongzhang Luo China 9 180 1.0× 221 1.4× 76 0.6× 69 0.9× 39 0.5× 12 381
Valentina Iacobelli Italy 11 166 0.9× 171 1.1× 80 0.7× 84 1.1× 55 0.8× 22 477
Maria M. Steele United States 12 319 1.8× 194 1.2× 168 1.4× 66 0.8× 40 0.5× 20 494

Countries citing papers authored by Guodong Deng

Since Specialization
Citations

This map shows the geographic impact of Guodong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guodong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guodong Deng more than expected).

Fields of papers citing papers by Guodong Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guodong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guodong Deng. The network helps show where Guodong Deng may publish in the future.

Co-authorship network of co-authors of Guodong Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Guodong Deng. A scholar is included among the top collaborators of Guodong Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guodong Deng. Guodong Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Jia, Yang Liu, Guodong Deng, et al.. (2024). Thermosensitive and injectable chitosan-based hydrogel embedding umbilical cord mesenchymal stem cells for β-cell repairing in type 2 diabetes mellitus. International Journal of Biological Macromolecules. 279(Pt 4). 135546–135546. 2 indexed citations
3.
Zheng, Wei, Hui Yuan, Guodong Deng, et al.. (2024). An effective two-stage NMBzA-induced rat esophageal tumor model revealing that the FAT-Hippo-YAP1 axis drives the progression of ESCC. Cancer Letters. 588. 216813–216813. 3 indexed citations
4.
Mao, Linlin, Guodong Deng, Mengfan Li, et al.. (2024). Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells. European journal of medical research. 29(1). 293–293. 3 indexed citations
5.
Wang, Chenlin, Yanan Wu, Chao Liu, et al.. (2024). Nervonic acid alleviates radiation-induced early phase lung inflammation by targeting macrophages activation in mice. Frontiers in Immunology. 15. 1405020–1405020. 2 indexed citations
6.
Wang, Fei, Guodong Deng, Ning Liang, et al.. (2023). Serum ferritin level is an effective prognostic factor for lung cancer immunotherapy. Cancer Biology & Therapy. 24(1). 2285367–2285367. 3 indexed citations
7.
Deng, Guodong, Yan Zhang, Lili Qiao, et al.. (2023). Ferritin in cancer therapy: A pleiotropic tumoraffin nanocage‐based transport. Cancer Medicine. 12(10). 11570–11588. 24 indexed citations
8.
9.
Liu, Kun, Yong Shi, Lili Qiao, et al.. (2022). The prognostic value of chemotherapy or/and radiotherapy in adenoid cystic carcinoma and adenoid basal carcinoma of the uterine cervix. Annals of Translational Medicine. 10(10). 554–554. 2 indexed citations
10.
Yang, Yanan, Guodong Deng, Lili Qiao, et al.. (2022). Identification and characterization of stem cells in mammalian esophageal stratified squamous epithelia. Journal of Molecular Cell Biology. 14(6). 8 indexed citations
11.
Qiao, Lili, Yanfei Chen, Ning Liang, et al.. (2022). Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies. Frontiers in Oncology. 12. 775238–775238. 29 indexed citations
12.
Xie, Jian, Lili Qiao, Guodong Deng, et al.. (2022). PCGF1 is a prognostic biomarker and correlates with tumor immunity in gliomas. Annals of Translational Medicine. 10(4). 227–227. 5 indexed citations
13.
Zou, Zhigeng, Wei Zheng, Guodong Deng, et al.. (2021). Aspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells. British Journal of Cancer. 125(6). 826–838. 11 indexed citations
14.
Luo, Hui, Xinshuang Yu, Ning Liang, et al.. (2017). The effect of induction chemotherapy in patients with locally advanced nonsmall cell lung cancer who received chemoradiotherapy. Medicine. 96(8). e6165–e6165. 13 indexed citations
15.
Liu, Qiqi, Lili Qiao, Pingping Hu, et al.. (2017). The effect of granulocyte and granulocyte-macrophage colony stimulating factors on tumor promotion.. PubMed. 22(1). 21–28. 6 indexed citations
16.
Zhang, Jingxin, Qiqi Liu, Lili Qiao, et al.. (2017). Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer. OncoTargets and Therapy. Volume 10. 2227–2237. 3 indexed citations
17.
18.
Zhang, Jingxin, Guoxia Zhang, Pingping Hu, et al.. (2017). Vasculogenic mimicry is associated with increased tumor-infiltrating neutrophil and poor outcome in esophageal squamous cell carcinoma. OncoTargets and Therapy. Volume 10. 2923–2930. 11 indexed citations
19.
Hu, Pingping, Qiqi Liu, Guodong Deng, et al.. (2017). The prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis. Scientific Reports. 7(1). 42913–42913. 43 indexed citations
20.
Liu, Qiqi, Lili Qiao, Ning Liang, et al.. (2016). The relationship between vasculogenic mimicry and epithelial‐mesenchymal transitions. Journal of Cellular and Molecular Medicine. 20(9). 1761–1769. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026